These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37390702)

  • 21. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient introduction of human telomerase mRNA improves hallmarks of progeria cells.
    Li Y; Zhou G; Bruno IG; Zhang N; Sho S; Tedone E; Lai TP; Cooke JP; Shay JW
    Aging Cell; 2019 Aug; 18(4):e12979. PubMed ID: 31152494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
    Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
    Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.
    García-Aguirre I; Alamillo-Iniesta A; Rodríguez-Pérez R; Vélez-Aguilera G; Amaro-Encarnación E; Jiménez-Gutiérrez E; Vásquez-Limeta A; Samuel Laredo-Cisneros M; Morales-Lázaro SL; Tiburcio-Félix R; Ortega A; Magaña JJ; Winder SJ; Cisneros B
    Aging Cell; 2019 Oct; 18(5):e13002. PubMed ID: 31305018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.
    Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
    Brassard JA; Fekete N; Garnier A; Hoesli CA
    Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
    Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
    Elife; 2015 Aug; 4():. PubMed ID: 26312502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hutchinson-Gilford progeria syndrome: Cardiovascular manifestations and treatment.
    Lian J; Du L; Li Y; Yin Y; Yu L; Wang S; Ma H
    Mech Ageing Dev; 2023 Dec; 216():111879. PubMed ID: 37832833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.
    Gonzalez JM; Pla D; Perez-Sala D; Andres V
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1133-46. PubMed ID: 21622261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS).
    Dreesen O
    Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry.
    Camafeita E; Jorge I; Rivera-Torres J; Andrés V; Vázquez J
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1.
    Zhang N; Hu Q; Sui T; Fu L; Zhang X; Wang Y; Zhu X; Huang B; Lu J; Li Z; Zhang Y
    Nat Aging; 2023 Feb; 3(2):185-201. PubMed ID: 37118121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome.
    Ferreira-Marques M; Carvalho A; Franco AC; Leal A; Botelho M; Carmo-Silva S; Águas R; Cortes L; Lucas V; Real AC; López-Otín C; Nissan X; de Almeida LP; Cavadas C; Aveleira CA
    Aging Cell; 2023 Dec; 22(12):e13983. PubMed ID: 37858983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.
    Egesipe AL; Blondel S; Lo Cicero A; Jaskowiak AL; Navarro C; Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
    NPJ Aging Mech Dis; 2016; 2():16026. PubMed ID: 28721276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hutchinson-Gilford Progeria Syndrome: An Overview of the Molecular Mechanism, Pathophysiology and Therapeutic Approach.
    Rahman MM; Ferdous KS; Ahmed M; Islam MT; Khan MR; Perveen A; Ashraf GM; Uddin MS
    Curr Gene Ther; 2021; 21(3):216-229. PubMed ID: 33655857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress.
    Trigueros-Motos L; Gonzalez JM; Rivera J; Andres V
    Front Biosci (Schol Ed); 2011 Jun; 3(4):1285-97. PubMed ID: 21622271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.